Prostate Cancer 2006 Edition
Foreword
These proceedings represent the consensual text and recommendation of the 16 committees that met in Paris at the occasion of the 6th International Consultation on New developments in Prostate Cancer and
Prostate Diseases June 24-27, 2005. On behalf of the International Consultation on Urological Diseases (ICUD) and its Steering Committee composed of the representatives of the major urological associations of the world (SIU, AUA, EAU, UAA, CAU) we would like to thank the chairmen and their committee members for again meeting the highest expectations. They bring us an updated overview of the basic premises in prostate cancer detection and prognosis followed by a thoroughly multiprofessional review of the different possible treatments in its different stages to conclude with updated consensus on chemoprevention and hormone supplements in the ageing male.
To emphasize the practical and educational approach to the subject, the proceedings finish with the view of the patient by an expert team representing all stakeholders in this disease.
The formula adopted in 1996 and 1999 shows no sign of fatigue with the innovations introduced each meeting.
Basically, of course, we stay with our time tested multiprofessional approach under the auspices of
the International Agency on Cancer Research, and the International Union against Cancer and advice from
the European Organisation on Research and Treatment of Cancer, the American Cancer Society and the
International Prostate Health Council that provides access and collaboration with some of the world’s best
experts on the disease. The Steering Committee, with support of the International Society of Urology,
assures the collaboration of the world’s urological experts on the subject in a truely global endeavour.
The 6th meeting brought us not only an updated present knowledge for the community, but focused on
evidence based facts and widely accepted recommendations with a model to define standards for clinical
research in the future. In short, a product that can serve as a reference and guide in the different aspects of
prostate cancer treatment prepared by a 150 member multidisciplinary and international team.
In meeting this milestone, we should not forget that this result was only possible by the advice and guidance
of the leading organizations, but also by the enthousiastic support of urologists from more than 20
national organizations.
We want to thank them all personally.
The Editors
J. McConnell, L. Denis, H. Akaza, S. Khoury, J Schalken
Copyright:
Reproduction of documents, whole or in part, will need permission from the authors.
Publications:
Our publications are in the popular Adobe Portable Document Format (PDF).
If you require Adobe Reader, a free copy can be downloaded from the Adobe Website.
